[Skystar Bio-Pharmaceuticalmpany Announces Two-for-One Stocklit XI'AN, CHINA November 5, 2009ystar Bio-Pharmaceuticalmpany (NASDAQ:BI) Shareholders of record of the close of market on November 16, 2009 will automatically be entitled to oneditional share ofmmon stock for each share owned. No action is required on the part of the shareholders, thempanys transferent willd thelit-adjusted shares to its records.]
[Skystar Bio-Pharmaceuticalmpany Announces Two-for-One Stocklit XI'AN, CHINA November 5, 2009ystar Bio-Pharmaceuticalmpany (NASDAQ:BI) Shareholders of record of the close of market on November 16, 2009 will automatically be entitled to oneditional share ofmmon stock for each share owned. No action is required on the part of the shareholders, thempanys transferent willd thelit-adjusted shares to its records.]
[ITEM 6. SELECTED FINANCIAL DATA In July 2005, we changed our fiscal year end from December 31 to March 31 beginning with the fiscal year ended March 31, 2005. The following selected consolidated financial data for the fiscal years ended March 31, 2009, 2008 and 2007 are derived from our audited consolidated financial statements included elsewhere in this Form 10-K.] [FORM 8-K CURRENT REPORT November 5th, 2009 Date of Report (Date of earliest event reported): SYNUTRA INTERNATIONAL, INC. Delaware 001-33397 13-4306188 (State or other jurisdiction of incorporation) (Commission (IRS Employer Identification No.) 2275 Research Blvd., Suite 500, Rockville, MD 20850 (ZIP Code) (301) 840-3888 N/A (Former name or former address, if changed since last report) o o o o Item]
[ITEM 6. SELECTED FINANCIAL DATA In July 2005, we changed our fiscal year end from December 31 to March 31 beginning with the fiscal year ended March 31, 2005. The following selected consolidated financial data for the fiscal years ended March 31, 2009, 2008 and 2007 are derived from our audited consolidated financial statements included elsewhere in this Form 10-K.] [FORM 8-K CURRENT REPORT November 5th, 2009 Date of Report (Date of earliest event reported): SYNUTRA INTERNATIONAL, INC. Delaware 001-33397 13-4306188 (State or other jurisdiction of incorporation) (Commission (IRS Employer Identification No.) 2275 Research Blvd., Suite 500, Rockville, MD 20850 (ZIP Code) (301) 840-3888 N/A (Former name or former address, if changed since last report) o o o o Item]
[ARTICLES SUPPLEMENTARY TO THE ARTICLES OF INCORPOATION OF BIOSTAR PHARMACEUTICALS, INC. Biostar Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Maryland (the “Corporation”), hereby certifies to the State Department of Assessments and Taxation of Maryland, that: Annex A SECOND: A description of the shares so classified with the preferences, conversions and other rights, voting] [--------------------------------------- BIOSTAR PHARMACEUTICALS, INC. Number of Shares: Holder: Exercise Price per Share: $3.00 Company Purchase Agreement Common Stock Exercise Price Expiration Date The Company hereby certifies that, for value received, __________, or registered assigns (the “ 1. . 2. Investment Representation . Person 3. . 4. a. b. 5. a. b. Date of Exercise A “ c. d. Net Number] [SECURITIES PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT Agreement Company Buyer Buyers Parties Party BACKGROUND WHEREAS 1933 Act Regulation D SEC WHEREAS Series B Preferred Stock Common Stock Securities WHEREAS Escrow Agent Closing Escrow Agreement WHEREAS Make Good Escrow Agent Make Good Escrow Agreement WHEREAS NOW, THEREFORE Article 1 INCORPORATION BY REFERENCE AND DEFINITIONS 1.1 Incorporation by Reference 1.2 Supersedes Other Agreements] [MAKE GOOD ESCROW AGREEMENT Agreement Company Purchasers Purchaser Escrow Agent Escrowing Parties This Agreement, dated as of November 2, 2009 (this “ WITNESSETH: WHEREAS Purchase Agreement ) Series B Preferred Stock Common Stock Securities Purchase Price WHEREAS WHEREAS NOW, THEREFORE, in consideration of the mutual promises herein contained and intending to be legally bound, the parties hereby agree as follows:] [CLOSING ESCROW AGREEMENT Agreement Company Purchasers Purchaser Escrow Agent Escrowing Parties This Agreement, dated as of November 2, 2009 (this “ WITNESSETH: WHEREAS Purchase Agreement ) Series B Preferred Stock Common Stock Securities Purchase Price WHEREAS Escrowed Funds WHEREAS NOW, THEREFORE, in consideration of the mutual promises herein contained and intending to be legally bound, the parties hereby agree as]
[ARTICLES SUPPLEMENTARY TO THE ARTICLES OF INCORPOATION OF BIOSTAR PHARMACEUTICALS, INC. Biostar Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Maryland (the “Corporation”), hereby certifies to the State Department of Assessments and Taxation of Maryland, that: Annex A SECOND: A description of the shares so classified with the preferences, conversions and other rights, voting] [--------------------------------------- BIOSTAR PHARMACEUTICALS, INC. Number of Shares: Holder: Exercise Price per Share: $3.00 Company Purchase Agreement Common Stock Exercise Price Expiration Date The Company hereby certifies that, for value received, __________, or registered assigns (the “ 1. . 2. Investment Representation . Person 3. . 4. a. b. 5. a. b. Date of Exercise A “ c. d. Net Number] [SECURITIES PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT Agreement Company Buyer Buyers Parties Party BACKGROUND WHEREAS 1933 Act Regulation D SEC WHEREAS Series B Preferred Stock Common Stock Securities WHEREAS Escrow Agent Closing Escrow Agreement WHEREAS Make Good Escrow Agent Make Good Escrow Agreement WHEREAS NOW, THEREFORE Article 1 INCORPORATION BY REFERENCE AND DEFINITIONS 1.1 Incorporation by Reference 1.2 Supersedes Other Agreements] [MAKE GOOD ESCROW AGREEMENT Agreement Company Purchasers Purchaser Escrow Agent Escrowing Parties This Agreement, dated as of November 2, 2009 (this “ WITNESSETH: WHEREAS Purchase Agreement ) Series B Preferred Stock Common Stock Securities Purchase Price WHEREAS WHEREAS NOW, THEREFORE, in consideration of the mutual promises herein contained and intending to be legally bound, the parties hereby agree as follows:] [CLOSING ESCROW AGREEMENT Agreement Company Purchasers Purchaser Escrow Agent Escrowing Parties This Agreement, dated as of November 2, 2009 (this “ WITNESSETH: WHEREAS Purchase Agreement ) Series B Preferred Stock Common Stock Securities Purchase Price WHEREAS Escrowed Funds WHEREAS NOW, THEREFORE, in consideration of the mutual promises herein contained and intending to be legally bound, the parties hereby agree as]
[Synutra International, Inc. Announces Appointment of Interim Chief Financial Officer QINGDAO, China & ROCKVILLE, Md.--(BUSINESS WIRE)--November 2, 2009--Synutra International, Inc. (NASDAQ: SYUT; “Synutra”), a leading infant formula company in China and a producer, marketer and seller of nutritional products for infants, children and adults, today announced the appointment of Joseph Chow as interim chief financial officer in place of Lawrence] [Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 2, 2009 Lawrence Lee, Chief Financial Officer (“CFO”) of Synutra International, Inc. (the “Company”), tendered his resignation as CFO to be effective November 10, 2009. On November 2, 2009, the Company appointed Joseph Chow as the interim CFO]
[Synutra International, Inc. Announces Appointment of Interim Chief Financial Officer QINGDAO, China & ROCKVILLE, Md.--(BUSINESS WIRE)--November 2, 2009--Synutra International, Inc. (NASDAQ: SYUT; “Synutra”), a leading infant formula company in China and a producer, marketer and seller of nutritional products for infants, children and adults, today announced the appointment of Joseph Chow as interim chief financial officer in place of Lawrence] [Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 2, 2009 Lawrence Lee, Chief Financial Officer (“CFO”) of Synutra International, Inc. (the “Company”), tendered his resignation as CFO to be effective November 10, 2009. On November 2, 2009, the Company appointed Joseph Chow as the interim CFO]
[China Wind Systems, Inc. No. 9 Yanyu Middle Road Qianzhou Village, Huishan District, Wuxi City Jiangsu Province, Peoples Republic of China Subscription Agreement Re: Gentlemen: 1.The Company is offering 2,400,000 Shares at a purchase price of $1.00 per share on a best efforts basis, with no minimum number of Shares being sold.As a result, the], [China Wind Systems, Inc. No. 9 Yanyu Middle Road Qianzhou Village, Huishan District, Wuxi City Jiangsu Province, Peoples Republic of China Subscription Agreement Re: Gentlemen: 1.The Company is offering 2,400,000 Shares at a purchase price of $1.00 per share on a best efforts basis, with no minimum number of Shares being sold.As a result, the], [VOTING AGREEMENT WITNESSETH: Agreement to Vote 1. (a)Barron hereby agrees that at any meeting of the stockholders of the Company, however called, and in any action by consent of the stockholders of the Company, with regards to the Covered Shares, Barron shall vote or cause to be voted or execute a written consent in favor]
[2020 ChinaCap Acquirco, Inc. Stockholders Approve Acquisition of Windrace International Company Limited “We are very pleased that our stockholders approved the acquisition of WHL,” stated George Lu, Chairman and Chief Executive Officer of 2020. “This transaction provides the business of WHL with a public listing on NASDAQ and the capital to execute its growth strategy of scaling up its distribution] []
